实例探究 > Increasing Research Throughput with an ELN for Chemists and Biologists

Increasing Research Throughput with an ELN for Chemists and Biologists

公司规模
200-1,000
地区
  • Europe
国家
  • Netherlands
产品
  • Dotmatics Platform
  • Studies Notebook ELN
  • Dotmatics Vortex
技术栈
  • Electronic Laboratory Notebook (ELN)
  • Data Visualization and Analytics
实施规模
  • Enterprise-wide Deployment
影响指标
  • Digital Expertise
  • Productivity Improvements
技术
  • 应用基础设施与中间件 - 数据可视化
  • 平台即服务 (PaaS) - 数据管理平台
适用行业
  • 医疗保健和医院
  • 药品
适用功能
  • 产品研发
  • 质量保证
用例
  • 质量预测分析
服务
  • 软件设计与工程服务
  • 系统集成
关于客户
Lead Pharma is a company that discovers and develops innovative therapeutics against cancer and autoimmune diseases. The company has unparalleled expertise in the discovery and optimization of first- and best-in class small molecules for challenging drug targets. Lead Pharma’s drug discovery engine combines adept medicinal, structural and computational chemistry capability with complementary expertise in the fields of cell biology and omics technologies. The company’s innovative approach enables isolation, purification and manufacture of target proteins and the development of biochemical, cellular, and functional reporter assays as well as biomarkers. Lead Pharma’s highly skilled workforce, many of which hold a PhD in Chemistry or Biology and have extensive experience across big pharma and biotech sectors, are based at state-of-the-art research laboratories at the Pivot Park in Oss, the Netherlands.
挑战
Lead Pharma’s new entity discovery and development capability has grown significantly during recent years. In response, assay throughputs and analysis requirements have increased within the company’s research functions and based on their experience within larger organizations, scientists at Lead Pharma were concerned about the limitations of traditional paper laboratory notebooks. Paper-based cross-referencing of scientific information heavily relied on team knowledge and was consequently vulnerable to staff turnover. Industry processes also required laboratory journals to be checked and countersigned by a scientific colleague or supervisor; a procedure dependent on the timely availability of appropriate staff members. Paper notebooks were used in combination with conventional Microsoft software packages (e.g. Excel, Word) and digital databases, resulting in a labor intensive, mixed-media approach.
解决方案
Lead Pharma sought an Electronic Laboratory Notebook (ELN) to replace their paper-based system that would also integrate with the company’s existing internal project database; the primary data repository for all structural and assay data. A key requirement was an ability to support both chemistry and biological science functions across the business. After a full market review, the Dotmatics Platform was selected. The Studies Notebook ELN addressed each of Lead Pharma’s specific challenges, with features and tools that offered value for chemists and biologists across the organization. Dotmatics Studies Notebook enabled signing and countersigning of experimental work, facilitated collaborative working and provided a fully searchable system that was easy to navigate via the interactive dashboard. The ELN allowed assay scientists to flexibly record experiments, new compounds to be recorded as individual studies in the system and experiments could be cloned to simplify protocols for production of compounds synthesized from a common reaction. In addition, Lead Pharma chose to license the Dotmatics Vortex product for advanced data visualization and analytics.
运营影响
  • Workflows have been streamlined by integrating the Dotmatics Platform with Lead Pharma’s existing chemistry database.
  • Processes and checks are simplified and may be conducted online.
  • The need for manual transcriptions is removed.
  • A digital and remotely accessible countersigning process is provided.
  • Colleagues are able to collaborate and share results or insights with ease.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。